The impact of genetic testing in dilated cardiomyopathy: are we yet in the era of precision medicine?

Back

HFA Premium Access

The impact of genetic testing in dilated cardiomyopathy: are we yet in the era of precision medicine?

Session: Chronic heart failure - epidemiology, prognosis, outcome 5

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor I. Campos (Penafiel, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ines Campos

Hospital Centre do Tamega e Sousa, Penafiel (Portugal)

2 presentations

0 follower

7 more presentations in this session

Lowest complications and total mortality with Intra-aortic balloon pump vs Impella despite adjustment for 54 variable or hospital types in patients with cardiogenic shock

Speaker: Professor M. Movahed (Tucson, US)

Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction

Speaker: Doctor M. Yang (Glasgow, GB)

Characteristics and treatment of contemporary real-world patients with cardiac transthyretin amyloidosis: a retrospective, multicenter, observational study

Speaker: Doctor R. Nies (Cologne, DE)

Interstitial volume overload and risk of adverse clinical events in ambulatory heart failure

Speaker: Doctor J. Montiel Perez (Valencia, ES)

Kidney failure risk equation and risk of kidney and cardiovascular outcomes in patients with heart failure with reduced ejection fraction: insights from PARADIGM-HF

Speaker: Doctor I. Beldhuis (Groningen, NL)

Access the full session

Chronic heart failure - epidemiology, prognosis, outcome 5

Speakers: Doctor I. Campos, Professor M. Movahed, Doctor M. Yang, Doctor R. Nies, Doctor J. Montiel Perez...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources